Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial

Document Details

Document Type
Pub Defense Publication
Publication Date
Jan 01, 2017
Source ID
10.1016/s1470-2045(16)30559-9

Entities

People

  • Alexandra Leary
  • Amit M. Oza
  • Ana Oaknin
  • Andrew R Allen
  • Anna V. Tinker
  • Anne Floquet
  • Clare L. Scott
  • David M. O'malley
  • Elaina Mann
  • Elizabeth M Swisher
  • Gottfried E. Konecny
  • Heidi Giordano
  • Iain A McNeish
  • Isabelle Ray-coquard
  • James D Brenton
  • James Sun
  • Janiel M Cragun
  • Jeff Isaacson
  • Katherine M Bell-mcguinn
  • Kevin K. Lin
  • Lara Maloney
  • Lindsey Rolfe
  • Ling Ma
  • Maria I. Harrell
  • Mitch Raponi
  • Rebecca S Kristeleit
  • Robert L Coleman
  • Roman Yelensky
  • Sandra Goble
  • Scott H Kaufmann
  • Thomas C. Harding

Organizations

  • Clovis Oncology
  • Ovarian Cancer Research Alliance
  • United States Department of Defense